Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000095

General Counsel sold 1,039 shares at $95.71 ($99,443)

From the SEC's structured data for this filing

Trades in this filing

Quinlan Paul T · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-15 Sale : show line 1 in the form −1,039 $95.71 $99,443 29,995 D
Open-market sales · 1,039 sh · avg $95.71 · $99,443
Loading xslF345X06/form4.xml…